Telmisartan Exacerbates Cisplatin-Induced Nephrotoxicity in a Mouse Model
Authors:
- 1 September 2020
- journal article
- research article
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 43 (9) , 1331-1337
Abstract
Cisplatin (CDDP; cis-diamine dichloroplatinum)-induced nephrotoxicity is the main reason for dose limitations, which can reduce the efficacy of cancer treatment. Lower blood pressure and administration of renin angiotensin system (RAS) inhibitors have been reported as factors that exacerbate CDDP-induced nephrotoxicity; however, the detailed mechanisms remain unknown and the results of previous studies are conflicting. In this study, we examined the influence of various hypotensive drugs, including RAS inhibitors and calcium channel blockers, on CDDP-induced nephrotoxicity in BALB/c mice. The mice were divided into nine groups: (1) CDDP group (15 mg/kg CDDP), (2) AML group (5 mg/kg amlodipine), (3) ENA group (2.5 mg/kg enalapril), (4) telmisartan (TEL) group (10 mg/kg telmisartan), (5) LOS group (10 mg/kg losartan), (6) CDDP + AML group, (7) CDDP + ENA group, (8) CDDP + TEL group, and (9) CDDP + LOS group. Nephrotoxicity was evaluated by measuring serum creatinine (CRE) and blood urea nitrogen (BUN) levels. In addition, the kidney sections were stained with Masson’s trichrome and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling (TUNEL) to assess the renal fibrosis area and apoptotic area. Serum CRE and BUN levels were increased in the CDDP + ENA, CDDP + LOS, and CDDP + TEL groups compared to those in the CDDP alone group, and the CDDP + AML group showed an increasing trend. However, there was no correlation between ∆CRE or ∆BUN levels and ∆ systolic blood pressure. The CDDP + TEL group showed a significant increase in the renal fibrosis area. These results suggest that exacerbation of CDDP-induced nephrotoxicity is not correlated with systolic blood pressure but is associated with administration of RAS inhibitors, particularly TEL.Keywords
This publication has 15 references indexed in Scilit:
- Comparative effects of different modes of renin angiotensin system inhibition on hypercholesterolaemia‐induced atherosclerosisBritish Journal of Pharmacology, 2012
- Mechanisms of Cisplatin NephrotoxicityToxins, 2010
- Nonhypotensive Dose of Telmisartan Attenuates Cognitive Impairment Partially Due to Peroxisome Proliferator-Activated Receptor-γ Activation in Mice With Chronic Cerebral HypoperfusionStroke, 2010
- Pharmacologically Induced Thoracic and Abdominal Aortic Aneurysms in MiceHypertension, 2010
- Protective Effects of the Angiotensin II Receptor Blocker Losartan on Cisplatin-Induced Kidney InjuryChemotherapy, 2009
- Angiotensin II Type 1 Receptor–Mediated Reduction of Angiotensin-Converting Enzyme 2 Activity in the Brain Impairs Baroreflex Function in Hypertensive MiceHypertension, 2009
- The phosphoinositide-3 kinase γ–Akt pathway mediates renal tubular injury in cisplatin nephrotoxicityKidney International, 2008
- Important role of apoptosis signal-regulating kinase 1 in ischemic acute kidney injuryBiochemical and Biophysical Research Communications, 2007
- Normotensive Ischemic Acute Renal FailureNew England Journal of Medicine, 2007
- Disparate Effects of Calcium Antagonists on Renal Microcirculation.Hypertension Research, 1996